Physician

Carrie Allison Mcilwain, MD

According to 2025 Medicare claims, Carrie Mcilwain, MD (NPI: 1053677005) practices gynecologist/oncologist in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is AFFILIATED ONCOLOGISTS, LLC (NPI: 1225314362; TIN: 274182621) and primary practice location at 60453-2199.

Mcilwain's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 212 traditional Medicare patients, billed 89,799 HCPCS/CPT codes, and received $2,396,677 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 116 prescription claims across 56 beneficiaries totaling $236,508 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). Open Payments data shows 7 records totaling $169. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $11,214 to $2,396,677. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $3,843 and ending at $236,508. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.4M2019 Medicare payment: $11,214 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $83,303 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $234,996 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $265,489 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $970,856 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,396,677 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
201946417$11,214
20202074,745$83,303
20212269,867$234,996
20222429,112$265,489
202319152,301$970,856
202421289,799$2,396,677

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$118K$237K2015 Drug cost: $3,843 (USD; Tot_Drug_Cst)2017 Drug cost: $5,143 (USD; Tot_Drug_Cst)2018 Drug cost: $13,455 (USD; Tot_Drug_Cst)2019 Drug cost: $6,665 (USD; Tot_Drug_Cst)2020 Drug cost: $22,660 (USD; Tot_Drug_Cst)2021 Drug cost: $1,951 (USD; Tot_Drug_Cst)2022 Drug cost: $3,900 (USD; Tot_Drug_Cst)2023 Drug cost: $29,476 (USD; Tot_Drug_Cst)2024 Drug cost: $236,508 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153565$3,843
2016N/RN/RN/R
20172649$5,143
201848139$13,455
20192558$6,665
20201948$22,660
20213378$1,951
202235109$3,900
202356125$29,476
202456116$236,508

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less63314$105
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more87136$102
96367Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less50261$23
99459Pelvic exam106157$18
J1100Injection, dexamethasone sodium phosphate, 1 mg442,936$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen32128$136
Medroxyprogesterone AcetateMedroxyprogesterone Acetate22597$127

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$169Merck Sharp & Dohme LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Carrie Allison Mcilwain, MD?

Tedicare shows public-source Medicare data for Carrie Allison Mcilwain, MD (NPI 1053677005), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carrie Allison Mcilwain, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Carrie Allison Mcilwain, MD?

Carrie Allison Mcilwain, MD is linked to AFFILIATED ONCOLOGISTS, LLC (billing NPI 1225314362) in the available physician profile data.

Does Carrie Allison Mcilwain, MD have Open Payments data?

Carrie Allison Mcilwain, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.